Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 25, 2022
Chemoimmunotherapy for EGFR-Mutant NSCLC: Still No Clear Answer
Bharathi Muthusamy, Nathan Pennell
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
July 4, 2007
Patients as real time teachers
Bernard M Bandman, Celia Engel Bandman, Nathan Pennell, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2022
Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng <i>et al</i>
Vidya Sankar Viswanathan, Mohammadhadi Khorrami, Khalid Jazieh, et al.
Investigational New Drugs
|
January 15, 2014
Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer
Neelesh Sharma, Nathan Pennell, Myles Nickolich, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 20, 2021
Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans
Mohammadhadi Khorrami, Kaustav Bera, Rajat Thawani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 9, 2022
Quantifying the Value of Multigene Testing in Resected Early Stage Lung Adenocarcinoma
Bharathi Muthusamy, Kira Raskina, Katherine T Lofgren, et al.
Plos One
|
October 26, 2018
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients
Monica Khunger, Pradnya Dinkar Patil, Arjun Khunger, et al.
Cancer Treatment and Research Communications
|
March 11, 2019
Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib
Jared Weiss, Brian Kavanagh, Allison Deal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2022
Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers
Nathaniel Braman, Prateek Prasanna, Kaustav Bera, et al.
Clinical Lung Cancer
|
October 4, 2025
Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC)
Shirish M Gadgeel, Misako Nagasaka, Karen Dziubek, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 25, 2022
Chemoimmunotherapy for EGFR-Mutant NSCLC: Still No Clear Answer
Bharathi Muthusamy, Nathan Pennell
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
July 4, 2007
Patients as real time teachers
Bernard M Bandman, Celia Engel Bandman, Nathan Pennell, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2022
Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng <i>et al</i>
Vidya Sankar Viswanathan, Mohammadhadi Khorrami, Khalid Jazieh, et al.
Investigational New Drugs
|
January 15, 2014
Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer
Neelesh Sharma, Nathan Pennell, Myles Nickolich, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 20, 2021
Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans
Mohammadhadi Khorrami, Kaustav Bera, Rajat Thawani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 9, 2022
Quantifying the Value of Multigene Testing in Resected Early Stage Lung Adenocarcinoma
Bharathi Muthusamy, Kira Raskina, Katherine T Lofgren, et al.
Plos One
|
October 26, 2018
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients
Monica Khunger, Pradnya Dinkar Patil, Arjun Khunger, et al.
Cancer Treatment and Research Communications
|
March 11, 2019
Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib
Jared Weiss, Brian Kavanagh, Allison Deal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2022
Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers
Nathaniel Braman, Prateek Prasanna, Kaustav Bera, et al.
Clinical Lung Cancer
|
October 4, 2025
Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC)
Shirish M Gadgeel, Misako Nagasaka, Karen Dziubek, et al.
Page
of 2